Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Multicenter Prospective Cohort of Sepsis and ARDS in China

A legfontosabb adatok

Ki végzi
Shanghai Zhongshan Hospital
Hol
Kína23 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
6000 fő, tervezett
Kezdés
2022. máj. 1.
Várható befejezés
2028. dec. 31.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • Surveys
  • 6-Minute Walk Test
  • Blood collection
  • Pulmonary & Respiratory Muscle Function Testing
  • CT Scan
  • Bronchoalveolar Lavage Fluid
  • HME filter samples
A regiszteradat frissítve
2026. október 7.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 12 feltétel megnézéseKevesebb

Ki vehet részt

  • Age ≥18 years
  • Meets the diagnostic criteria for sepsis and/or acute respiratory distress syndrome (ARDS):; Sepsis: Sepsis is defined according to the Sepsis-3 criteria as suspected or confirmed infection accompanied by acute organ dysfunction attributable to infection, operationalized as an increase in the Sequential Organ Failure Assessment (SOFA) score of ≥2 points from baseline; ARDS: ARDS is diagnosed according to the 2024 Global Definition of ARDS, including an acute predisposing condition or risk factor, acute onset or worsening of respiratory symptoms, bilateral pulmonary opacities on chest imaging or lung ultrasound not fully explained by pleural effusion, atelectasis, or pulmonary nodules, hypoxemia meeting the corresponding oxygenation criteria, and pulmonary edema not primarily attributable to cardiogenic causes or fluid overload
  • Admitted to an ICU or other designated inpatient unit at a participating study center, including emergency or respiratory care units where appropriate
  • Written informed consent is obtained from the participant or a legally authorized representative, or deferred consent is used when permitted by local ethical requirements

Ki nem vehet részt

  • Previous enrollment in this cohort. Each participant may be enrolled only once; subsequent episodes of sepsis and/or ARDS may be recorded as clinical events but will not result in repeated enrollment
  • Participant withdrawal: Participants or their legally authorized representatives may withdraw consent at any time. No new study-specific data will be collected after withdrawal. The use of previously collected data and stored biological samples will follow the participant's consent and applicable ethical requirements
  • The acute clinical condition is primarily explained by an alternative diagnosis without sepsis or ARDS, such as isolated cardiogenic pulmonary edema or fluid overload without ARDS
  • Terminal illness with an expected survival of <24 hours, or a decision for comfort measures only has been made before enrollment
  • Any other condition that, in the investigator's judgment, makes participation inappropriate; Withdrawal and Loss to Follow-up:
  • Investigator-initiated withdrawal: Participants may be withdrawn if subsequent review identifies a major protocol violation, duplicate enrollment, unreliable study data, or another condition that makes continued participation inappropriate
  • Informed consent cannot be obtained in accordance with applicable ethical requirements
  • Loss to follow-up: Participants who cannot be contacted after repeated attempts and for whom follow-up information cannot be obtained through other permitted sources will be considered lost to follow-up. Data collected before loss to follow-up may be retained and analyzed according to the statistical analysis plan

Ez a vizsgálat jelenleg itt érhető el: Kína.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This prospective, multicenter, observational cohort study enrolls 6,000 adults with sepsis and/or acute respiratory distress syndrome (ARDS) at multiple hospitals in China. Clinical data, treatment information, biological samples, and follow-up data are collected to characterize patient features and outcomes and to establish a multicenter clinical cohort and biobank.

A teljes eredeti leírásKevesebb

The study focuses on the clinical and biological heterogeneity of sepsis and ARDS. Longitudinal clinical data are integrated with information on organ function, inflammatory and immune responses, and multi-omics profiles to identify clinically relevant phenotypes and biological subgroups. Biomarkers associated with disease severity, organ dysfunction, treatment response, and mortality are explored, together with models for outcome prediction. Follow-up after hospitalization evaluates long-term survival and recovery, including pulmonary function, physical function, quality of life, and psychological health.

A vizsgálat 2 csoportja

  • Hospitalized Cohort

    Patients with Sepsis/ARDS enrolled during hospitalization will undergo prospective collection of clinical data and biospecimens during the acute phase of illness. Clinical characteristics, treatments, organ support, and in-hospital outcomes will also be recorded.

    Kezelés: Blood Collection, Bronchoalveolar Lavage Fluid és HME filter samples

  • Long-term Follow-up Cohort

    Participants enrolled in the hospitalized Sepsis/ARDS cohort who survive and are available for follow-up will undergo longitudinal assessments at 1, 6, 12, and 24 months following hospital discharge, including evaluation of quality of life, physical function, pulmonary function, imaging, and biospecimen collection.

    Kezelés: Surveys, 6-Minute Walk Test, Blood collection, Pulmonary & Respiratory Muscle Function Testing és CT Scan

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Sepsis and Acute Respiratory Distress Syndrome in China (SEARCH): A Multicenter Prospective Observational Study of Clinical and Biological Phenotypes
A regiszteradat frissítve
2026. október 7.